» Articles » PMID: 20732275

Stereospecific in Vitro Embryotoxicity of L-homocysteine in Pre- and Post-implantation Rodent Embryos

Overview
Specialty Toxicology
Date 2010 Aug 25
PMID 20732275
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Recently a derangement of homocysteine metabolism has been suggested as a possible risk factor for neural tube defects and recurrent spontaneous abortion. To investigate a possible role of homocysteine in the aetiology of neural tube defects we tested the in vitro embryotoxicity of l-homocysteine by culturing day 10 post coitum post-implantation rat embryos in whole embryo culture (WEC) for 24 hr and day 2 post coitum pre-implantation mouse embryos for 48 hr. With an area under curve (AUC) of 6.3 mm/hr, l-homocysteine significantly reduced the percentage of mouse embryos that developed into blastocysts. In rat WEC, an AUC for l-homocysteine of 3.6 mm/hr reduced the mitotic index of the neural epithelium of the rhombencephalon and the cell density of the mesenchyme adjacent to it, while at an AUC of 7.2 mm/hr l-homocysteine reduced the total morphological score and the number of malformations was increased. Malformations most often seen were transparent rhombencephalon, no or delayed formation of forelimb buds, dysmorphogenesis of the somites, and blister formation dorso-laterally of the place of forelimb bud formation. The embryotoxicity of l-homocysteine was stereospecific since d-homocysteine caused no embryotoxic effects. Also the oxidation product l-homocystine (AUC, 72 mm/hr) and the metabolite l-methionine (AUC, 144 mm/hr) were not embryotoxic. Both stereoisomers of homocysteinethiolactone were embryotoxic at an AUC of 72 mm/hr. The results are discussed in relation to the metabolism of homocysteine and methionine and their possible role in the neurulation process.

Citing Articles

Predictive value of homocysteine levels in embryo culture media for embryo selection in infertile patients with endometriosis.

Imamoglu M, Oncul M, Tuten A, Senturk L Turk J Obstet Gynecol. 2025; 22(1):26-34.

PMID: 40062656 PMC: 11894767. DOI: 10.4274/tjod.galenos.2025.43669.


Homocysteine Metabolites, Endothelial Dysfunction, and Cardiovascular Disease.

Jakubowski H, Witucki L Int J Mol Sci. 2025; 26(2).

PMID: 39859460 PMC: 11765536. DOI: 10.3390/ijms26020746.


Discovery of a novel homocysteine thiolactone hydrolase and the catalytic activity of its natural variants.

Hou S, Liu H, Hu Y, Zhang J, Deng X, Li Z Protein Sci. 2024; 33(8):e5098.

PMID: 38980003 PMC: 11232049. DOI: 10.1002/pro.5098.


5-Methyltetrahydrofolate and Vitamin B12 Supplementation Is Associated with Clinical Pregnancy and Live Birth in Women Undergoing Assisted Reproductive Technology.

Cirillo M, Fucci R, Rubini S, Coccia M, Fatini C Int J Environ Res Public Health. 2021; 18(23).

PMID: 34886014 PMC: 8657301. DOI: 10.3390/ijerph182312280.


Inhibiting MARSs reduces hyperhomocysteinemia-associated neural tube and congenital heart defects.

Mei X, Qi D, Zhang T, Zhao Y, Jin L, Hou J EMBO Mol Med. 2020; 12(3):e9469.

PMID: 32003121 PMC: 7059139. DOI: 10.15252/emmm.201809469.